Patent details

Basic Information

Publication number:

EP3503920

PCT Application Number:

US2017047721

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178441986

PCT Publication Number:

WO2018039097

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-CTLA4 ANTIBODIES

French Title of Invention:

ANTICORPS ANTI-CTLA4

German Title of Invention:

ANTI-CTLA4-ANTIKÖRPER

SPC Number:

Dates

Filing date:

21/08/2017

Grant date:

08/05/2024

EP Publication Date:

03/07/2019

PCT Publication Date:

01/03/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/05/2024

EP B1 Publication Date:

08/05/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/08/2024

Expiration date:

21/08/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/05/2024

 

 

Name:

Akeso Biopharma, Inc.

Address:

6 Shennong Road Torch Development Zone, Zhongshan, Guangdong 528437, China (CN)

Inventor

1

Name:

WANG, Zhongmin

Address:

China (CN)

2

Name:

XIA, Yu

Address:

China (CN)

3

Name:

LI, Baiyong

Address:

China (CN)

4

Name:

ZHANG, Peng

Address:

China (CN)

5

Name:

PANG, Xinghua

Address:

China (CN)

Priority

Priority Number:

PCT/CN2016/096357

Priority Date:

23/08/2016

Priority Country:

World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:

A61K 39/395; C07K 16/18; C07K 16/28; C12N 15/09;

Publication

European Patent Bulletin

Issue number:

202419

Publication date:

08/05/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages